Trials / Recruiting
RecruitingNCT02016430
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- Sponsor
- The Cleveland Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Our group has recently identified the association between gut-flora-mediated carnitine and phosphatidylcholine metabolism, specifically trimethylamine-N-oxide (TMAO), and cardiovascular risk. This study investigates the ability for dietary intervention to modulate TMAO levels.
Detailed description
This is a pilot human study to characterize the relationship between gut flora-associated TMAO generation and dietary intervention. The investigators hypothesize that tailored dietary interventions may help to reduce the ability for gut flora to generate TMAO in individuals with elevated TMAO levels. Specific aims include: 1. To investigate the proportion of subjects with persistently elevated circulating TMAO levels. 2. To compare the amount of TMAO generated from gut flora using stable-isotope-labelled choline, carnitine, and betaine in subjects with elevated versus normal circulating TMAO levels. 3. To evaluate the effect of dietary interventions on the amount of TMAO generated from gut flora using stable-isotope-labelled choline, carnitine, and betaine in subjects with elevated circulating TMAO levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | MeLT Dietary intervention | Mediterranean diet containing food with low TMAO content. |
| BEHAVIORAL | TLC Dietary intervention | Standard American Heart Association (AHA) recommendations for dietary counseling. |
| BEHAVIORAL | MeLT dietary intervention with TMAO | Mediterranean diet containing food with low TMAO content with TMAO levels provided to the subject for guidance. |
Timeline
- Start date
- 2014-04-04
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2013-12-20
- Last updated
- 2025-10-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02016430. Inclusion in this directory is not an endorsement.